Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Nature Communications|November 2, 2023
Charge-altering releasable transporters enhance mRNA delivery in vitro and exhibit in vivo tropismZhijian Li, Laura Amaya, Ruoxi Pi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2017
Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animalsColin J McKinlay, Jessica R Vargas, Timothy R Blake, et al.
The Journal of Organic Chemistry|November 17, 2020
Function-Oriented Synthesis: Design, Synthesis, and Evaluation of Highly Simplified Bryostatin AnaloguesPaul A Wender, Jack L Sloane, Quang H Luu-Nguyen, et al.
Cancer Research|January 30, 2019
Local Delivery of <i>Ox40l</i>, <i>Cd80</i>, and <i>Cd86</i> mRNA Kindles Global Anticancer ImmunityOle Audun Werner Haabeth, Timothy R Blake, Colin J McKinlay, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
TPPB modulates PKC activity to attenuate neuroinflammation and ameliorate experimental multiple sclerosisShruthi Shanmukha, Wesley H Godfrey, Payam Gharibani, et al.
Scientific Reports|August 9, 2017
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activationBrice J Albert, Austin Niu, Rashmi Ramani, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
<i>In Vivo</i> Targeting of Escherichia coli with Vancomycin-ArginineLewis F Neville, Itamar Shalit, Peter A Warn, et al.
Cell Chemical Biology|January 20, 2021
Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammationEfrat Abramson, Clayton Hardman, Akira J Shimizu, et al.
Science Advances|January 24, 2025
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIVZachary O Gentry, Owen D McAteer, Jennifer L Hamad, et al.
Pathogens & Immunity|May 20, 2024
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer CellsMelanie Dimapasoc, Jose A Moran, Steve W Cole, et al.
Pageof 23